# Study on Allogeneic Osteoblastic Cells Implantation in Rescue Interbody Fusion

> **NCT02328287** · PHASE2 · TERMINATED · sponsor: **Bone Therapeutics S.A** · enrollment: 6 (actual)

## Conditions studied

- Failed Lumbar Fusion

## Interventions

- **DRUG:** ALLOB®

## Key facts

- **NCT ID:** NCT02328287
- **Lead sponsor:** Bone Therapeutics S.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09
- **Primary completion:** 2018-04
- **Final completion:** 2020-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02328287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02328287, "Study on Allogeneic Osteoblastic Cells Implantation in Rescue Interbody Fusion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02328287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*